The Reduction in Risk of Ovarian Cancer Associated with Oral-Contraceptive Use

New England Journal of Medicine

Volumn 316, Issue 11, 1987, Pages 650-655

 

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; ETYNODIOL DIACETATE; MESTRANOL; NORETHISTERONE; NORETYNODREL; NORGESTREL; ORAL CONTRACEPTIVE AGENT;

CANCER RISK; CONTROLLED STUDY; DRUG FORMULATION; DRUG MIXTURE; DRUG THERAPY; ENDOCRINE SYSTEM; FEMALE GENITAL SYSTEM; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; OVARY CANCER; PREVENTION; PRIORITY JOURNAL; RISK; THERAPY;

ADULT; AGE FACTORS; CARCINOMA; CONTRACEPTIVES, ORAL; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; PARITY; REGISTRIES; RISK; TIME FACTORS; UNITED STATES;

EID: 0023099029     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198703123161102     Document Type: Article

References (34)

1. Newhouse ML, Pearson RM, Fullerton JM, Boesen EAM, Shannon HS. A case control study of carcinoma of the ovary. Br J Prev Soc Med 1977; 31: 148–53.
2. Casagrande JT, Louie EW, Pike MC, Roy S, Ross RK, Henderson BE. “Incessant ovulation” and ovarian cancer. Lancet 1979; 2: 170–3.
3. McGowan L, Parent L, Lednar W, Noms HJ. The woman at risk for developing ovarian cancer. Gynecol Oncol 1979; 7: 325–44.
4. Annegers JF, Strom H, Decker DG, Dockerty MB, O'Fallon WM. Ovarian cancer: incidence and case–control study. Cancer 1979; 43: 723–9.
5. Hildreth NG, Kelsey JF, LiVolsi VA, et al. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol 1981; 114: 398–405.
6. Weiss NS, Lyon JL, Liff JM, Vollmer WM, Daling JR. Incidence of ovarian cancer in relation to the use of oral contraceptives. Int J Cancer 1981; 28: 669–71.
7. Willett WC, Bain C, Hennekens CH, Rosner B, Speizer FE. Oral contraceptives and risk of ovarian cancer. Cancer 1981; 48: 1684–7.
8. Rosenberg L, Shapiro S, Slone D, et al. Epithelial ovarian cancer and combination oral contraceptives. JAMA 1982; 247: 3210–2.
9. Franceschi S, La Vecchia C, Helmrich SP, Mangioni C, Tognoni G. Risk factors for epithelial ovarian cancer in Italy. Am J Epidemiol 1982; 115: 714–9.
10. Cramer DW, Hutchison GB, Welch WR, Scully RE, Knapp RC. Factors affecting the association of oral contraceptives and ovarian cancer. N Engl J Med 1982; 307: 1047–51.
11. Tzonou A, Day NE, Trichopoulos D, et al. The epidemiology of ovarian cancer in Greece: a case–control study. Eur J Cancer CHn Oncol 1984; 20: 1045–52.
12. Oral contraceptive use and the risk of ovarian cancer: the Centers for Disease Control Cancer and Steroid Hormone Study. JAMA 1983; 249: 1596–9.
13. Long-term oral contraceptive use and the risk of breast cancer: the Centers for Disease Control Cancer and Steroid Hormone Study. JAMA 1983; 249: 1591–5.
14. Stadel BV, Rubin GL, Webster LA, Schlesselman JJ, Wingo PA. Oral contraceptives and breast cancer in young women. Lancet 1985; 2: 970–3.
15. Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc 1978; 73: 40–6.
16. Hartge P, Brinton LA, Rosenthal JF, Cahill JI, Hoover RN, Waksberg J. Random digit dialing in selecting a population-based control group. Am J Epidemiol 1984; 120: 825–33.
17. Côté RA, ed. College of American Pathologists, Committee on Nomenclature and Classification of Disease. Systematized nomenclature of medicine. 2nd ed. Vol. 1. Skokie, Ill.: College of American Pathologists, 1979.
18. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. JNCI 1959; 22: 719–48.
19. Schlesselman JJ. Case–control studies: design, conduct, analysis. New York: Oxford University Press, 1982.
20. Harrell FE Jr. The Logist procedure: SUGI supplemental library user's guide. Cary, N.C.: SAS Institute, 1983:181–202.
21. Fleiss JL. Statistical methods for rates and proportions. 2nd ed. New York: John Wiley, 1981.
22. Cornfield J. A statistical problem arising from retrospective studies. In: Neyman J, ed. Proceedings of the third Berkeley symposium on mathematical statistics and probability. Vol. IV. Berkeley, Calif.: University of California Press, 1956:135–48.
23. Coulter A, Vessey M, McPherson K, Crossley B. The ability of women to recall their oral contraceptive histories. Contraception 1986; 33: 127–37.
24. Joly DJ, Lilienfeld AM, Diamond EL, Bross IDJ. An epidemiologic study of the relationship of reproductive experience to cancer of the ovary. Am J Epidemiol 1974; 99: 190–209.
25. Nasca PC, Greenwald P, Chorost S, Richart R, Caputo T. An epidemiologic case–control study of ovarian cancer and reproductive factors. Am J Epidemiol 1984; 119: 705–13.
26. Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. JNCI 1983; 71: 717–21.
27. Fathalla MF. Incessant ovulation — a factor in ovarian neoplasia? Lancet 1971; 2: 163.
28. Stadel BV. The etiology and prevention of ovarian cancer. Am J Obstet Gynecol 1975; 123: 772–3.
29. Goldzieher JW, de la Peña A, Chenault CB, Woutersz TB. Comparative studies of the ethynyl estrogens used in oral contraceptives. II. Antiovulatory potency. Am J Obstet Gynecol 1975; 122: 619–24.
30. Mishell DR Jr. Oral steroids. In: Mishell DR Jr, Davajan V, eds. Reproductive endocrinology, infertility and contraception. Philadelphia: FA Davis, 1979:487–523.
31. Dericks-Tan JSE, Krög W, Aktories K, Taubert H-D. Dose-dependent inhibition by oral contraceptives of the pituitary to release LH and FSH in response to stimulation with LH-RH. Contraception 1976; 14: 171–81.
32. Scott JZ, Kletzky OA, Brenner PF, Mishell DR Jr. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function. Fertil Steril 1978; 30: 141–5.
33. Spellacy WN, Kalra PS, Buhi WC, Birk SA. Pituitary and ovarian responsiveness to a graded gonadotropin releasing factor stimulation test in women using a low-estrogen or a regular type of oral contraceptive. Am J Obstet Gynecol 1980; 137: 109–15.
34. Young JL Jr, Pollack ES. The incidence of cancer in the United States. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. Philadelphia: WB Saunders, 1982:138–65.